Bone Fibrosis: Causes, Symptoms & Treatment
Bone fibrosis is a condition in which normal bone tissue is replaced by fibrous connective tissue, reducing bone strength and function.
Things worth knowing about "Bone Fibrosis"
Bone fibrosis is a condition in which normal bone tissue is replaced by fibrous connective tissue, reducing bone strength and function.
What is Bone Fibrosis?
Bone fibrosis (also called osteofibrosis) is a pathological condition in which healthy bone tissue is progressively replaced by fibrous connective tissue. This remodeling process impairs the mechanical integrity and normal function of the skeleton. Bone fibrosis can occur as a primary condition or as a complication of various underlying diseases.
Causes
Several conditions and factors can lead to bone fibrosis:
- Primary hyperparathyroidism: Excessive secretion of parathyroid hormone (PTH) accelerates bone resorption, leading to fibrous replacement known as osteitis fibrosa cystica.
- Secondary hyperparathyroidism: Commonly associated with chronic kidney disease, where impaired mineral metabolism causes sustained bone damage.
- Paget disease of bone: A chronic metabolic bone disorder characterized by abnormal bone remodeling.
- Fibrous dysplasia: A genetic condition in which bone tissue is replaced by fibrous tissue during development.
- Radiation damage: Radiation therapy directed at bony structures can induce fibrotic changes.
- Tumors and bone metastases: Metastatic lesions can trigger localized fibrotic reactions within the bone.
- Myelofibrosis: A bone marrow disorder in which blood-forming marrow is replaced by fibrous scar tissue.
Symptoms
The clinical presentation of bone fibrosis varies depending on the severity and location of the disease:
- Bone pain, particularly with physical activity or weight bearing
- Increased bone fragility and elevated fracture risk
- Bone deformities and swelling
- Muscle weakness and general fatigue
- When the bone marrow is affected: anemia, increased susceptibility to infections, and bleeding tendencies
- Localized pain in affected skeletal regions such as the spine, pelvis, or femur
Diagnosis
Diagnosis is based on a combination of clinical, laboratory, and imaging findings:
- Imaging studies: X-rays, computed tomography (CT), and magnetic resonance imaging (MRI) reveal characteristic bone changes.
- Bone scintigraphy: A nuclear medicine scan used to assess metabolic activity in the skeleton.
- Laboratory tests: Measurement of calcium, phosphate, parathyroid hormone (PTH), alkaline phosphatase, and other bone turnover markers.
- Bone biopsy: Histological examination of a bone sample provides definitive confirmation of fibrous tissue replacement.
Treatment
Treatment is directed at the underlying cause of the fibrosis:
Treatment of Hyperparathyroidism
In primary hyperparathyroidism, surgical removal of the affected parathyroid gland (parathyroidectomy) is the treatment of choice. Secondary hyperparathyroidism related to chronic kidney disease is managed with phosphate binders, vitamin D analogues, and calcimimetics.
Pharmacological Therapy
- Bisphosphonates (e.g., zoledronic acid) inhibit bone resorption and are used across multiple forms of bone fibrosis.
- Denosumab, a monoclonal antibody, also targets bone resorption pathways.
- Analgesics and anti-inflammatory medications to relieve symptoms.
Surgical Interventions
Severe bone deformities or unstable fractures may require surgical management, including osteosynthesis or joint replacement with endoprostheses.
Treatment of Myelofibrosis
Myelofibrosis is treated with JAK inhibitors (e.g., ruxolitinib), and in eligible patients, allogeneic stem cell transplantation offers the only potentially curative approach.
Prognosis
The prognosis of bone fibrosis depends significantly on the underlying cause, the extent of bone involvement, and how early the condition is diagnosed. When the root cause is treated promptly, progression can be halted or slowed. In advanced cases, permanent structural bone changes may remain.
References
- Rosen, C.J. (ed.) - Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 8th edition. Wiley-Blackwell, 2013.
- Kumar, V., Abbas, A.K., Aster, J.C. - Robbins & Cotran Pathologic Basis of Disease, 10th edition. Elsevier, 2020.
- World Health Organization (WHO) - Global guidelines on chronic kidney disease-mineral and bone disorder (CKD-MBD). Available at: www.who.int
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryWeight loss
Chlorine dioxide
Calorie expenditure
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Bone Fibrosis-en